SEC v. Matthew Groom

Matthew Groom allegedly avoided losses of about $13,000 by trading in advance of the May 3, 2022 announcement by the Cambridge, Massachusetts-based biopharmaceutical company Spero Therapeutics, Inc., according to the SEC. Groom allegedly obtained material nonpublic information about Spero’s planning for a possible workforce reduction.

Summary generated from official Securities and Exchange Commission press release